SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) March 31, 1998
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On March 31, 1998 Biocontrol Technology, Inc.
(NASDAQ:BICO) announced today in response to another article in a
local Pittsburgh newspaper that the Company repeats its adamant
denial of any wrongdoing in connection with the development of
its noninvasive glucose sensor. The Company also states that it
has no reason to believe that any of the other broad,
unsubstantiated allegations contained in the article are
meritorious; neither the Company nor any of its legal counsel
have been notified of any of the alleged federal investigations.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: March 31, 1998
BICO
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
Release: Immediate
For More Information, Call:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.279.9455 phone
1.412.279.9690 fax 1.412.279.9447 fax
BIOCONTROL DENIES WRONGDOING
Pittsburgh, PA - March 31, 1998 - Biocontrol
Technology, Inc. (Nasdaq:BICO) announced today in response to
another article in a local Pittsburgh newspaper that the Company
repeats its adamant denial of any wrongdoing in connection with
the development of its noninvasive glucose sensor. The Company
also states that it has no reason to believe that any of the
other broad, unsubstantiated allegations contained in the article
are meritorious; neither the Company nor any of its legal counsel
have been notified of any of the alleged federal investigations.
Biocontrol recently obtained ISO 9001 certification and, as
reported on March 17, 1998, the Company has completed the
Technical File for obtaining the CE Mark necessary for European
marketing and distribution.
Biocontrol Technology, Inc. (www.bico.com) has its
corporate offices in Pittsburgh, PA and is involved in the
development and manufacture of biomedical devices and
environmental products.
